Close this search box.

Clinical guidance for ME/CFS may also help Long COVID patients

Updated clinical guidance for myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS), produced by the US ME/CFS Clinician Coalition, may also help patients who remain ill with Long COVID after even mild cases of COVID-19. An article about the update has been published in Mayo Clinic Proceedings:

Read it here

Recent research suggests 10 percent or more of adults with acute COVID-19 may go on to develop ME/CFS. Patients with ME/CFS have long struggled to access clinical care as a result of a lack of accurate clinical guidance and provider knowledge. The significant influx of new ME/CFS cases has created an urgent need for clinicians everywhere to learn about this disease.

The updated clinical guidance from the US ME/CFS Clinician Coalition focuses on adults and includes: 

  • New diagnostic criteria requiring post-exertional malaise and other key features to improve diagnostic accuracy
  • Efficient use of interview questions, physical examination findings, and diagnostic testing
  • Alternative diagnoses and co-existing conditions to consider
  • Pharmacological and nonpharmacological treatments
  • A discussion of why previously-recommended treatments — cognitive behavioral therapy and graded exercise therapy — can be harmful and are no longer recommended

There are no FDA-approved treatments for ME/CFS. However, authors of the article state that, in their experience, improvement is possible with appropriate care, and  provide their consensus recommendations with a variety of available treatments.

Author Dr. Lucinda Bateman notes:

“There are many steps clinicians can take now to improve the health, function, and quality of life of people with ME/CFS, including those newly ill with ME/CFS following COVID-19. This guidance may also help Long COVID patients, even if they do not fully meet criteria for ME/CFS.”

Watch the accompanying video by Dr. Lucinda Bateman:

Donate to Open Medicine Foundation and help those with ME/CFS return to the healthy lives they deserve:

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.

How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669